Ophthalmology: The M&A Landscape

Vertical: Ophthalmology
Author: JC Lupis
Date: March 2020

Private equity groups and strategic acquirers are showing a high degree of interest in the ophthalmology market. Consolidation is somewhat less mature than in the dermatology sector, although the pace of merger and acquisition activity in the past year or two suggests that platform groups will be harder to find and acquirers will be turning their eye more towards tuck-in acquisitions and specialty areas, such as retina.

The table below illustrates the extent of activity in the market in Q1 2020 alone.

Ophthalmology Market: Key Table

Selection of Ophthalmology Providers Entering Partnerships in Q1 2020

GHA-Ophthalmology-Deals-Q1-2020

Ophthalmology Market: Key Data Point

One study counted 186 private equity (PE) or PE-backed acquisitions of ophthalmology or optometry practices from 2017 through 2019, up from 42 between 2012 and 2016.

Source: VMG Health, 2019 Healthcare M&A Report, May 2019

GHA’s Ophthalmology Market Brief includes the following sections:

  • Ophthalmology Market-At-A-Glance
  • Ophthalmology Market Developments
  • What Do Acquirers Consider?
  • The Mergers & Acquisitions Landscape

To inquire about a copy, please contact research@ghadvisors.net.